April Mission of the Month
The April Mission of the month is CYSTIC FIBROSIS. It is a rare and fatal genetic disease. About 30,000 people in the United States and 70,000 people worldwide have CF. The defective CF gene and its protein product causes persistent and debilitating lung infections that often lead to premature death. The disease also stops the absorption of food leading to poor growth. The predicted median age of survival for CF has doubled in the past 30 years as a result of CF Foundation-driven improvements in research and care.
The mission of the Cystic Fibrosis Foundation (CFF) is to cure cystic fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment and ensuring access to high-quality, specialized care. CFF is the world's leader in the search for a cure for cystic fibrosis and funds more CF research than any other organization, and nearly every CF drug available today was made possible because of CFF support.
The Cystic Fibrosis Foundation is supported by donations from individuals and corporations and does not receive any federal funding.